The 19th International congress on Myelodysplastic Syndrome (MDS 2027)

The 19th International congress on Myelodysplastic Syndrome (MDS 2027) is a conference dedicated to the the latest developments in the Myelodysplastic Syndrome field.

Topics

• Diagnosis (flow cytometry, morphology and molecular)
• Clinical Management
• Pathogenesis (immunological, molecular, animal models and cellular)
• Epidemiology (quality of life, demographics and co-morbidity)
• Prognostic Factors and Models
• Childhood MDS
• Stem Cell Transplantation
• Supportive Care including Iron Chelation Therapy
• Therapy (low-risk MDS and high-risk MDS)

Who should Attend

Scientists and educators working with MDS and hematology to discuss quality of life, long-term care and longevity of patients suffering from this debilitating disease.